Personal information

Other IDs

Loop profile: 749735

Keywords

intestinal epithelial barrier, gut microbiota, Helicobacter pylori, gut barrier, Clostridium Difficile

Countries

China

Activities

Collapse all

Employment (1)

Nanfang Hospital, Southern Medical University: Guangzhou, Guangdong Province, CN

1993-08 to present | Professor (Gastroenterology)
Employment
Source: Self-asserted source
Ye Chen

Education and qualifications (2)

Baylor College of Medicine: Houston, TX, US

2002-09 to 2006-08 | Postdoc (Medicine)
Education
Source: Self-asserted source
Ye Chen

First Military Medical University: Guangzhou, CN

1994-08 to 2000-07 | MD, PhD
Education
Source: Self-asserted source
Ye Chen

Professional activities (2)

Chinese Society of Gastroenterology: Beijing, CN

2018 to present | member
Membership
Source: Self-asserted source
Ye Chen

Youth Committee of CSG: Guangzhou, CN

2010 to 2017 | Vice chairman
Membership
Source: Self-asserted source
Ye Chen

Works (10)

Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy.

Journal of cellular and molecular medicine
2019-03-25 | Journal article
Part of DOI: 10.1111/jcmm.14289
Part of PMC: PMC6484301
Source: Self-asserted source
Ye Chen

Half-dose clarithromycin-containing bismuth quadruple therapy is effective and economical in treating Helicobacter pylori infection: A single-center, open-label, randomized trial.

Helicobacter
2019-02-19 | Journal article
DOI: 10.1111/hel.12566
PMID: 30780194
Source: Self-asserted source
Ye Chen

The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.

Nature communications
2019-02-08 | Journal article
DOI: 10.1038/s41467-018-08225-3
PMID: 30737378
PMC: PMC6368584
Source: Self-asserted source
Ye Chen

Testing the neutral theory of biodiversity with the microbiome dataset from cystic fibrosis patients.

Medicine
2018-09-01 | Journal article
DOI: 10.1097/MD.0000000000012248
PMID: 30212959
PMC: PMC6156045
Source: Self-asserted source
Ye Chen

Furazolidone-containing triple and quadruple eradication therapy for initial treatment for Helicobacter pylori infection: A multicenter randomized controlled trial in China.

Helicobacter
2018-07-22 | Journal article
DOI: 10.1111/hel.12496
PMID: 30033619
Source: Self-asserted source
Ye Chen

Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection.

Helicobacter
2018-03-07 | Journal article
DOI: 10.1111/hel.12475
PMID: 29512258
Source: Self-asserted source
Ye Chen

Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.

Journal of cellular and molecular medicine
2018-02-07 | Journal article
DOI: 10.1111/jcmm.13508
PMID: 29411528
PMC: PMC5867062
Source: Self-asserted source
Ye Chen

Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.

Inflammatory bowel diseases
2018-02-01 | Journal article
DOI: 10.1093/ibd/izx059
PMID: 29462386
PMC: PMC5936643
Source: Self-asserted source
Ye Chen

Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction.

mSystems
2018-01-30 | Journal article
DOI: 10.1128/mSystems.00188-17
PMID: 29404425
PMC: PMC5790872
Source: Self-asserted source
Ye Chen

Metformin protects against intestinal barrier dysfunction via AMPKα1-dependent inhibition of JNK signalling activation.

Journal of cellular and molecular medicine
2017-11-17 | Journal article
DOI: 10.1111/jcmm.13342
PMID: 29148173
PMC: PMC5742676
Source: Self-asserted source
Ye Chen
How many people are using ORCID?